DermaGen

Sweden
Lund, Skane Lan, Sweden
+46 46 192 197 ★

Company profile

DermaGen company profile

DermaGen develops peptide therapeutics for topical use based on novel and proprietary antimicrobial peptides (AMPs). We intend to be a leading R&D company in this area with the aim of offering innovative and profitable licensing opportunities to selected pharmaceutical companies with significant market potential. DermaGen focuses on R&D to provide new and patented products initially for dermatological indications. DermaGen has selected its first candidate drug (CD), which has entered the development phase. To help advance development of our product portfolio and to bring them to market, we welcome the interest of new investors, partners and collaborators.

Business identity

Contact email
[email protected]
Phone number
+46 46 192 197
Operating status
Closed
Company type
For Profit
Employee range
00001-00010 employees
Founded
2004-05-01

Headquarters

Headquarters
Lund, Skane Lan, Sweden
Postal code
223 63
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Series Unknown / 2008-04-02
Last equity funding
Series Unknown
Investors
3
Closed on
2011-09-07

Founders and investors

Investors

KarolinskaMidroc New TechnologyOstersjöstiftelsen

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.